In a murine lung adenocarcinoma model and murine skin melanoma model, SETDB1 inhibits endogenous retrovirus expression and the type I interferon response and restrains antitumour immunity during radiotherapy, suggesting that downregulation of SETDB1 may be a promising way to enhance the efficacy of radiotherapy [14]. This evidence concerns the gene SETDB1 and cutaneous melanoma.